Amedisys to buy Boston hospice for $125 million

Author Profile Image
Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.

Amedisys says it has reached a deal to buy Beacon Hospice, one of the largest hospice companies in New England, for $125 million. Beacon Hospice, based in Boston, has 23 locations across Massachusetts, Maine, New Hampshire, Rhode Island and Connecticut. The company had $80 million in revenue last year. James T. Robinson, executive vice president of Amedisys hospice care, says Beacon has an average of 1,300 patients a day. “The addition of Beacon will increase the number of hospice patients under our care by nearly 40%,” Robinson says. Amedisys has a hospice in New Hampshire, so the deal will expand its presence in the Northeast. The deal is expected to add 5 to 7 cents to Amedisys’ earnings this year, excluding one-time transaction costs.

Discussion (0)

From Our Partners

Daily Report Poll

ASK AI

Ask anything about Baton Rouge business